Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SONNENBLICK, M.
Right arrow Articles by SHILO, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SONNENBLICK, M.
Right arrow Articles by SHILO, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 Oxford University Press

research-article

GLIBENCLAMIDE INDUCED PROLONGED HYPOGLYCAEMIA

M. SONNENBLICK, Senior Physician and Lecturer and S. SHILO, Senior Physician and Lecturer

Department of Geriatrics, Shaare Zedek Medical Center P.O. Box 293, Jerusalem 91002, Israel
Department of Medicine, Shaare Zedek Medical Center P.O. Box 293, Jerusalem 91002, Israel

Prolonged hypoglycaemia (serum glucose levels of 50 mg/dl and less, for more than 12 h in spite of treatment with periodic injections of hypertonic glucose) secondary to treatment with glibenclamide was found in 13 hospitalized patients. The mean daily dose of glibenclamide was 6.7 mg. In nine patients, the hypoglycaemia developed within 7 days of treatment. In two patients the tendency to hypoglycaemia lasted for more than 60 h in spite of continuous infusion of 5% or 10% glucose. Old age seems to be a crucial predisposing factor as none of the patients was under the age of 68 years. Contributing factors were renal failure and congestive heart disease. We feel that glibenclamide should be used with care in the elderly and in patients with renal or cardiac failure.

accepted in revised form January 7, 1986.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JRSMHome page
A. P Webber and C. Benjamin
Wandering hemiparesis
J R Soc Med, January 1, 2004; 97(1): 26 - 27.
[Full Text] [PDF]

Home page
 JRSMHome page
P Y P Kwong and J D Teale
Screening for sulphonylureas in the investigation of hypoglycaemia
J R Soc Med, January 8, 2002; 95(8): 381 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
H. Ben-Ami, P. Nagachandran, A. Mendelson, and Y. Edoute
Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Arch Intern Med, February 8, 1999; 159(3): 281 - 284.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.